Metraipolis › archive › dc_60791e408fbb

A phase 1 randomized safety, reactogenicity, and immunogenicity study of Typhax: A novel protein capsular matrix vaccine candidate for the prevention of… — Europe PMC PMID:31905228

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/31905228
DOI
10.1371/journal.pntd.0007912
License (as archived)
solo-consultazione
Archived
2026-10-08T06:03:08.263Z
SHA-256 of the archived text
9b5c7f4b8bde941e48fd70847ce7c118cb003cc34f3b29eece4349777fc5de0a
Stable URL of this page
https://metraipolis.com/documento/dc_60791e408fbb

How to cite

A phase 1 randomized safety, reactogenicity, and immunogenicity study of Typhax: A novel protein capsular matrix vaccine candidate for the prevention of… — Europe PMC PMID:31905228 — Europe PMC (en), https://europepmc.org/article/MED/31905228 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_60791e408fbb (Metraipolis archive dc_60791e408fbb, sha256 9b5c7f4b8bde941e48fd70847ce7c118cb003cc34f3b29eece4349777fc5de0a)
BibTeX
@misc{dc60791e408fbb,
  title = {A phase 1 randomized safety, reactogenicity, and immunogenicity study of Typhax: A novel protein capsular matrix vaccine candidate for the prevention of… — Europe PMC PMID:31905228},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/31905228},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_60791e408fbb; sha256 9b5c7f4b8bde941e48fd70847ce7c118cb003cc34f3b29eece4349777fc5de0a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/31905228. Agents can read the archived copy with the MCP tool read_document.